tiprankstipranks
Trending News
More News >
Ambu A/S Class B (AMBFF)
OTHER OTC:AMBFF

Ambu (AMBFF) Price & Analysis

Compare
39 Followers

AMBFF Stock Chart & Stats

$12.90
$0.00(0.00%)
At close: 4:00 PM EDT
$12.90
$0.00(0.00%)

Ambu News

AMBFF FAQ

What was Ambu A/S Class B’s price range in the past 12 months?
Ambu A/S Class B lowest stock price was $12.40 and its highest was $21.00 in the past 12 months.
    What is Ambu A/S Class B’s market cap?
    Ambu A/S Class B’s market cap is $3.67B.
      When is Ambu A/S Class B’s upcoming earnings report date?
      Ambu A/S Class B’s upcoming earnings report date is Feb 04, 2026 which is in 23 days.
        How were Ambu A/S Class B’s earnings last quarter?
        Ambu A/S Class B released its earnings results on Nov 05, 2025. The company reported $0.067 earnings per share for the quarter, missing the consensus estimate of $0.082 by -$0.015.
          Is Ambu A/S Class B overvalued?
          According to Wall Street analysts Ambu A/S Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ambu A/S Class B pay dividends?
            Ambu A/S Class B pays a Annually dividend of $0.064 which represents an annual dividend yield of 0.46%. See more information on Ambu A/S Class B dividends here
              What is Ambu A/S Class B’s EPS estimate?
              Ambu A/S Class B’s EPS estimate is 0.08.
                How many shares outstanding does Ambu A/S Class B have?
                Ambu A/S Class B has 234,974,400 shares outstanding.
                  What happened to Ambu A/S Class B’s price movement after its last earnings report?
                  Ambu A/S Class B reported an EPS of $0.067 in its last earnings report, missing expectations of $0.082. Following the earnings report the stock price went same 0%.
                    Which hedge fund is a major shareholder of Ambu A/S Class B?
                    Currently, no hedge funds are holding shares in AMBFF
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Ambu A/S Class B

                      Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

                      Ambu (AMBFF) Earnings & Revenues

                      AMBFF Company Deck

                      AMBFF Earnings Call

                      Q4 2025
                      0:00 / 0:00
                      Earnings Call Sentiment|Neutral
                      The earnings call reflects a strong performance in key growth areas such as endoscopy and respiratory solutions, supported by strategic investments and a positive cash flow. However, challenges from FX, tariffs, and specific segment growth constraints present notable risks, balancing the overall outlook.View all AMBFF earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Teleflex
                      Conmed
                      Merit Medical Systems
                      Insulet
                      Atricure
                      Inogen

                      Ownership Overview

                      18.12%<0.01%78.23%
                      Insiders
                      <0.01% Other Institutional Investors
                      78.23% Public Companies and
                      Individual Investors

                      Options Prices

                      Currently, No data available
                      ---
                      Popular Stocks